Sanjivani Paranteral LtdPharmaceuticalsINE860D01013Standalone₹179.80-1.00 (-0.55%)Jun-26
Valuation
Market Cap₹220.87 Cr
TTM PE29.33x
Forward PE28.09x
PEG0.67
Book Value₹30.93
P/B5.81x
TTM EPS₹6.13
Fwd EPS₹6.40
TTM Revenue₹66.33 Cr
TTM PAT₹7.50 Cr
TTM EBITDA₹10.15 Cr
TTM EBIT₹9.13 Cr
Last Qtr PAT₹2.30 Cr
Last Qtr EBITDA₹3.40 Cr
Last Qtr EBIT₹3.09 Cr
Profitability
ROE19.74%
ROCE23.00%
TTM NPM11.31%
TTM EBITDA %15.30%
Curr OPM11.79%
Last OPM8.91%
Curr NPM
Last NPM
Curr EPS₹1.87
Last EPS₹0.80
Balance sheet
Equity₹11.88 Cr
Reserve₹26.11 Cr
Total Debt₹8.14 Cr
D/E0.21x
Interest %7.83%
Curr Interest₹0.18 Cr
Price / range
Close₹179.80
vs 52W High-31.88%
vs 52W Low+42.70%
MA50
MA200
Returns
1D-0.55%
1W-0.47%
1M-10.53%
3M+21.57%
6M+14.16%
1Y-24.91%
2Y-42.52%
3Y+71.24%
5Y+481.88%
Diwali-21.28%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr148.173.58%
DIVISLAB9375.00₹2.49L Cr84.6217.55%
TORNTPHARM4840.00₹1.84L Cr78.8025.43%
ZYDUSLIFE1160.00₹1.16L Cr33.2112.96%
CIPLA1394.50₹1.13L Cr36.648.93%
LAURUSLABS1954.00₹1.06L Cr120.9216.46%
AUROPHARMA1734.00₹99.77K Cr38.796.84%
DRREDDY1185.00₹98.91K Cr148.681.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue19.46+8.8%10.5120.8615.5017.8964.76
Other Income0.150.750.290.160.041.24
Total Income19.61+9.4%11.2621.1515.6617.9366
Interest0.180.060.210.050.220.54
Expenditure-16.55-6.1%-10.01-17.67-13.47-15.60-56.77
PBDT000000
EBITDA3.40+27.3%0.913.592.252.679.39
Depreciation-0.31-0.35-0.19-0.17-0.16-0.86
EBIT3.09+23.1%0.563.402.082.518.53
PBT3.06+33.0%1.253.492.192.309.23
Tax-0.77-0.31-0.87-0.55-0.50-2.31
Equity000000
OPM15.7311.9016.7214.1412.8614.00
Net Profit2.30+32.9%0.942.621.641.736.92
NPM11.798.9112.5410.589.6710.00
EPS1.870.802.131.3305.67

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue64.76-7.6%70.10+28.8%54.41+53.3%35.49+15.9%30.61+22.0%25.10
Other Income1.241.210.520.550.240.26
Total Income66-7.4%71.31+29.8%54.93+52.4%36.05+16.8%30.86+21.7%25.36
Expenditure-56.77+6.9%-60.95-28.7%-47.36-52.3%-31.10-19.7%-25.98-8.5%-23.95
Interest-0.54-0.59-0.25-0.36-0.21-0.13
PBDT000000
EBITDA9.39-9.4%10.36+25.9%8.23+45.9%5.64-1.4%5.72+167.3%2.14
Depreciation-0.86-0.62-0.93-0.89-0.88-0.86
EBIT8.53-12.4%9.74+33.4%7.30+53.7%4.75-1.9%4.84+278.1%1.28
PBT9.23-10.9%10.36+36.9%7.57+53.2%4.94+1.2%4.88+246.1%1.41
Tax-2.31-2.26-1.41-0.43-0.030.01
Equity011.880000
OPM (%)14.0014.5314.0014.0016.006.00
Net Profit6.92-14.6%8.10+31.3%6.17+36.8%4.51-7.0%4.85+241.5%1.42
NPM (%)10.0011.3611.0013.0016.006.00
EPS (Rs)5.67-17.7%6.89+30.5%5.28+17.1%4.51-7.0%4.85+190.4%1.67
CEPS5.676.675.284.514.851.67

Consolidated

16 lines · 6 periods
MetricDec-25Sep-25Jun-25Mar-25Dec-24FY24-25
Revenue22.06+27.1%18.5017.8918.1817.3570.10
Other Income0.300.160.040.430.311.22
Total Income22.36+26.6%18.6617.9318.6117.6671.31
Interest0.210.050.220.200.190.59
Expenditure-18.66-23.2%-13.47-15.60-15.90-15.15-60.96
PBDT000000
EBITDA3.84+50.6%5.252.672.662.5510.35
Depreciation-0.23-0.17-0.16-0.18-0.16-0.62
EBIT3.61+51.0%5.082.512.482.399.73
PBT3.70+47.4%5.192.302.652.5110.35
Tax-0.92-0.55-0.50-0.40-0.61-2.26
Equity0000011.88
OPM16.5427.8212.8314.2614.2114.52
Net Profit2.78+46.3%4.641.732.191.908.09
NPM12.4224.869.6611.7510.7511.35
EPS2.21+36.4%3.781.461.841.626.89

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 1 years
MetricFY 24-25
Revenue70.10
Other Income1.22
Total Income71.31
Expenditure-60.96
Interest-0.59
PBDT0
EBITDA10.35
Depreciation-0.62
EBIT9.73
PBT10.35
Tax-2.26
Equity11.88
OPM (%)14.52
Net Profit8.09
NPM (%)11.35
EPS (Rs)6.89
CEPS6.66

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

1
YearTypeAmountEx-Date
2025Final Dividend0.519 Sep 2025

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers